Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Label-free Cell Analyzer

By Drug Discovery Trends Editor | July 14, 2008

Roche Applied Science announces the launch of the xCELLigence System, a cell-based assay system that represents the perfect integration of micro electronics and cell biology. xCELLigence is Roche’s new cell analyzer system, originally invented by US-based ACEA Biosciences, and co-developed by Roche and ACEA. The xCELLigence system will be marketed exclusively by Roche on a worldwide basis.

The design of the electronic sensor, innovative techniques to collect and assess data and optimised instrumentation make this system a unique platform for cell-based assays and provide a benchmark potential for cellular and molecular biology. Continuous measurement is performed label free and fast – the system needs less than 15 seconds to analyze a 96 well E Plate.

The xCELLigence System is composed of four main components: the RTCA Analyzer, the RTCA SP Station, the RTCA Computer and integrated Software,  and the disposable 96-well microtiter E-Plate. The RTCA SP Station is located inside a standard tissue culture incubator and is capable of switching any one of the wells on the E-Plate 96 to the RTCA Analyzer for impedance measurement. Under precise software control, the RTCA SP Analyzer automatically selects wells for measurement and continuously transfers measured impedance data to the computer. Cell Index values, derived from the measured impedances, are continuously displayed in real time by the software user interface. This allows for easy setup and customization of assay protocols and for simplified integrated, on-line data analysis.

The heart of the technique is a micro-electronic biosensor which is built into each well of the standard 16- or 96-well E Plate microtiter plates. A cell which has contact with the sensor changes the electrical impedance between the microelectrodes. Each change in the cell’s status – for example, changes in cell adhesion, cytotoxicity, cell proliferation, cell – cell interactions, and morphological changes – leads to changes in the impedance measurements and can therefore be easily and quickly detected in real time. Labelling of the cells, which can induce non-physiological changes in the cells, is not necessary. The system is label free and requires no reporters.

It is suitable for uninterrupted monitoring of processes in living cells and for monitoring real-time kinetics. The system supplies a densely concentrated stream of information and shows excellent sensitivity and reproducibility when monitoring the overall cell population of a cell culture.

Roche Applied Science 


Filed Under: Drug Discovery

 

Related Articles Read More >

Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE